__NUXT_JSONP__("/drugs/Glesatinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"936694-12-1",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable, small-molecule, multitargeted tyrosine kinase inhibitor with potential antineoplastic activity. Glesatinib binds to and inhibits the phosphorylation of several receptor tyrosine kinases (RTKs), including the c-Met receptor (hepatocyte growth factor receptor); the Tek\u002FTie-2 receptor; vascular endothelial growth factor receptor (VEGFR) types 1, 2, and 3; and the macrophage-stimulating 1 receptor (MST1R or RON). Inhibition of these RTKs and their downstream signaling pathways may result in the inhibition of tumor angiogenesis and tumor cell proliferation in tumors overexpressing these RTKs.",fdaUniiCode:"7Q29OXD98N",identifier:"C77876",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C129825","C1967"],synonyms:["GLESATINIB",a,"MG90265","MG90265X","MGCD265","TKI MGCD265"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FGlesatinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Glesatinib","","2021-10-30T13:44:53.683Z")));